Related Experiment Video
Updated: Sep 30, 2025

Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
Single serine on TSC2 exerts biased control over mTORC1 activation mediated by ERK1/2 but not Akt
Brittany L Dunkerly-Eyring1,2, Shi Pan1, Miguel Pinilla-Vera1
1Division of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Abstract:
Tuberous sclerosis complex-2 (TSC2) negatively regulates mammalian target of rapamycin complex 1 (mTORC1), and its activity is reduced by protein kinase B (Akt) and extracellular response kinase (ERK1/2) phosphorylation to activate mTORC1. Serine 1364 (human) on TSC2 bidirectionally modifies mTORC1 activation by pathological growth factors or hemodynamic stress but has no impact on resting activity. We now show this modification biases to ERK1/2 but not Akt-dependent TSC2-mTORC1 activation. Endothelin-1-stimulated mTORC1 requires ERK1/2 activation and is bidirectionally modified by phospho-mimetic (S1364E) or phospho-silenced (S1364A) mutations. However, mTORC1 activation by Akt-dependent stimuli (insulin or PDGF) is unaltered by S1364 modification. Thrombin stimulates both pathways, yet only the ERK1/2 component is modulated by S1364. S1364 also has negligible impact on mTORC1 regulation by energy or nutrient status. In vivo, diet-induced obesity, diabetes, and fatty liver couple to Akt activation and are also unaltered by TSC2 S1364 mutations. This contrasts to prior reports showing a marked impact of both on pathological pressure-stress. Thus, S1364 provides ERK1/2-selective mTORC1 control and a genetic means to modify pathological versus physiological mTOR stimuli.
Insights
Tuberous sclerosis complex-2 (TSC2) phosphorylation at Serine 1364 specifically controls extracellular signal-regulated kinase (ERK1/2)-mediated mammalian target of rapamycin complex 1 (mTORC1) activation, not Akt-dependent pathways. This finding offers a targeted approach to modulate mTORC1 signaling.
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Biochemistry
Background:
- Tuberous sclerosis complex-2 (TSC2) is a key negative regulator of mTORC1 signaling.
- Phosphorylation of TSC2 by Akt and ERK1/2 kinases activates mTORC1.
- Serine 1364 (S1364) on TSC2 is a critical modification site influencing mTORC1 activity.
Purpose of the Study:
- To investigate the specific role of TSC2 S1364 phosphorylation in modulating mTORC1 activation by different signaling pathways.
- To differentiate between ERK1/2-dependent and Akt-dependent TSC2-mTORC1 activation.
- To determine the in vivo relevance of S1364 modifications in metabolic conditions.
Main Methods:
- Utilized phospho-mimetic (S1364E) and phospho-silenced (S1364A) TSC2 mutations in cellular models.
- Stimulated mTORC1 signaling with various agonists including Endothelin-1, insulin, PDGF, and thrombin.
- Assessed mTORC1 activation in response to S1364 modifications under basal and stimulated conditions, including in vivo models of diet-induced obesity.
Main Results:
- TSC2 S1364 modification specifically impacts ERK1/2-dependent mTORC1 activation, not Akt-dependent pathways.
- Endothelin-1 and thrombin-induced mTORC1 activation were modulated by S1364 mutations, while insulin and PDGF effects were unaltered.
- S1364 modifications showed negligible effects on mTORC1 regulation by energy status and were unaltered in diet-induced obesity and diabetes models in vivo.
Conclusions:
- TSC2 S1364 phosphorylation provides a selective mechanism for controlling ERK1/2-mediated mTORC1 activation.
- This site offers a means to genetically distinguish pathological mTORC1 stimuli from physiological ones.
- The findings highlight the pathway-specific role of TSC2 S1364 in mTORC1 regulation.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

